methylphenidate has been researched along with Autosomal Dominant Cerebellar Ataxia, Type II in 2 studies
Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Spinocerebellar ataxia type 17 (SCA17) is a rare autosomal dominantly inherited neurodegenerative disorder presenting with a variable phenotype including ataxia, dystonia, chorea, and parkinsonism, as well as cognitive impairment." | 1.38 | PET and MRI reveal early evidence of neurodegeneration in spinocerebellar ataxia type 17. ( Brockmann, K; Globas, C; Hauser, TK; Machulla, HJ; Reimold, M; Rolfs, A; Schöls, L; Walter, U, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brockmann, K | 1 |
| Reimold, M | 2 |
| Globas, C | 1 |
| Hauser, TK | 1 |
| Walter, U | 1 |
| Machulla, HJ | 2 |
| Rolfs, A | 1 |
| Schöls, L | 1 |
| Wüllner, U | 1 |
| Abele, M | 1 |
| Bürk, K | 1 |
| Minnerop, M | 1 |
| Dohmen, BM | 1 |
| Bares, R | 1 |
| Klockgether, T | 1 |
2 other studies available for methylphenidate and Autosomal Dominant Cerebellar Ataxia, Type II
| Article | Year |
|---|---|
PET and MRI reveal early evidence of neurodegeneration in spinocerebellar ataxia type 17.
Topics: Adult; Age of Onset; Brain; Dopamine Agents; Dopamine Antagonists; Dopaminergic Neurons; Female; Flu | 2012 |
Dopamine transporter positron emission tomography in spinocerebellar ataxias type 1, 2, 3, and 6.
Topics: Adult; Binding, Competitive; Biomarkers; Brain; Brain Mapping; Dopamine; Dopamine Plasma Membrane Tr | 2005 |